Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis

Ovarian Cancer Clinical Trial

Official title:

Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02769546
• Other study ID #: UPCC 28815
• Status: Terminated
• Start date: January 2016
• Est. completion date: January 2018

Study information

• Verified date: April 2020
• Source: Abramson Cancer Center of the University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The primary objective is to administer a cross-sectional survey to directly compare the differences patients and physicians hold regarding ovarian cancer prognosis and survival, complications arising from treatment, and counseling on advance directives, living wills, palliative care, and hospice services. Overall, the project will pinpoint opportunities for better patient physician communication regarding prognosis and end-of-life care and allow for more informed and tailored decision-making.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 50
• Est. completion date: January 2018
• Est. primary completion date: January 2018
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• women over 18 years old with biopsy-confirmed malignancy

• being actively treated or are in surveillance for epithelial ovarian cancer

• have an existing therapeutic relationship with a provider who is participating in the study.

Exclusion Criteria:

• patients enrolled in palliative or hospice care programs, patients with a second primary malignancy within the last five years (excluding non-melanoma skin cancer)

• patients who are illiterate or non-English speaking, and patients without decision-making capacity.

• There are no exclusion criteria based on age, gender, economic status or race/ethnicity

Related Conditions & MeSH terms

• Carcinoma, Ovarian Epithelial
• Ovarian Cancer
• Ovarian Neoplasms

Intervention

Other:
• Surveys

Locations

Country	Name	City	State
United States	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Abramson Cancer Center of the University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of completed surveys and phone interviews		1 year